Volta Medical SAS | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
Volta Medical SAS

BRIEF

published on 07/23/2024 at 14:05, 3 months 28 days ago

Volta Medical Collaborates with GE HealthCare to Enhance Arrhythmia Procedures

Electrophysiology Volta Medical Atrial Fibrillation GE HealthCare AI-driven Technologies
PRESS RELEASE

published on 07/23/2024 at 14:00, 3 months 28 days ago

Volta Medical Enters into Joint Development Agreement with GE HealthCare to Enhance Arrhythmia Procedures with AI-Driven Electrophysiology Technologies
Volta Medical partners with GE HealthCare to enhance arrhythmia procedures using AI-driven electrophysiology technologies. Collaboration focuses on improving patient outcomes for atrial fibrillation

Electrophysiology AI-driven Volta Medical Atrial Fibrillation GE HealthCare
BRIEF

published on 05/20/2024 at 14:05, 6 months ago

Volta Medical reveals results of first AI-assisted cardiac ablation trial

Artificial Intelligence Cardiology Clinical Test Volta Medical Atrial Fibrillation
PRESS RELEASE

published on 05/20/2024 at 14:00, 6 months ago

Volta Medical presents results from first transatlantic randomized controlled trial comparing AI-assisted ablation procedure with conventional treatment for persistent atrial fibrillation patients
Volta Medical presents positive results from a transatlantic randomized controlled trial comparing AI-assisted ablation with conventional treatment for persistent atrial fibrillation patients

Volta Medical Transatlantic Trial AI-assisted Ablation Persistent Atrial Fibrillation Clinical Trial Results
BRIEF

published on 05/09/2024 at 14:05, 6 months 11 days ago

Volta Medical Gains Recognition in International Cardiac Electrophysiology Consensus

Artificial Intelligence Cardiac Electrophysiology Volta Medical Atrial Fibrillation Ablation TAILORED-AF Clinical Trial
PRESS RELEASE

published on 05/09/2024 at 14:00, 6 months 11 days ago

Volta Medical Featured in Latest Consensus Statement from Leading International Cardiac Electrophysiology Societies on Atrial Fibrillation Ablation
Volta Medical featured in latest consensus statement by global cardiac electrophysiology societies on atrial fibrillation ablation, highlighting AI companion and TAILORED-AF trial

Cardiac Electrophysiology Volta Medical Atrial Fibrillation Ablation Consensus Statement TAILORED-AF Trial
BRIEF

published on 04/18/2024 at 14:05, 7 months 2 days ago

Volta Medical will present innovative results in cardiac electrophysiology

Artificial Intelligence Clinical Test Volta Medical Atrial Fibrillation Heart Rhythm Conference
PRESS RELEASE

published on 04/18/2024 at 14:00, 7 months 2 days ago

Volta Medical Announces Late-Breaking TAILORED-AF Randomized Clinical Trial Results at Heart Rhythm 2024 in Boston, MA, USA
Volta Medical announces late-breaking TAILORED-AF randomized clinical trial results at Heart Rhythm 2024 in Boston, featuring AI solutions for complex cardiac arrhythmias

AI Solutions Volta Medical TAILORED-AF Randomized Clinical Trial Heart Rhythm 2024
PRESS RELEASE

published on 01/05/2023 at 09:30, 1 year 10 months ago

Volta Medical Secures €36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation, New CFO Introduced

Accesswire

Published on 11/21/2024 at 10:03, 46 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 49 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 49 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 14 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 24 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 19 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 44 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 47 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 49 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 49 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 51 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 29 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 4 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 4 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE